Symbol:
Mnda
Name:
myeloid cell nuclear differentiation antigen
Description:
Predicted to have double-stranded DNA binding activity and transcription coregulator activity. Predicted to be involved in several processes, including activation of immune response; cellular response to cytokine stimulus; and negative regulation of B cell proliferation. Predicted to localize to the nuclear inclusion body; nucleolus; and nucleoplasm. Orthologous to several human genes including MNDA (myeloid cell nuclear differentiation antigen); INTERACTS WITH 1-naphthyl isothiocyanate; 4,4'-diaminodiphenylmethane; amphetamine.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Also known as:
Ifi204; interferon activated gene 204; LOC304988; rHin-3
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
MNDA (myeloid cell nuclear differentiation antigen) RGD
RGD
Homo sapiens (human):
MNDA (myeloid cell nuclear differentiation antigen) RGD
RGD
Mus musculus (house mouse):
Ifi211 (interferon activated gene 211) RGD
RGD
Mus musculus (house mouse):
Ifi204 (interferon activated gene 204) RGD
RGD
Pan paniscus (bonobo/pygmy chimpanzee):
MNDA (myeloid cell nuclear differentiation antigen) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
LOC488622 (interferon-activable protein 203) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
IFI16 (interferon gamma inducible protein 16) HGNC
EggNOG, HomoloGene, OrthoDB, Panther, PhylomeDB
Homo sapiens (human):
PYHIN1 (pyrin and HIN domain family member 1) HGNC
OMA, OrthoDB, Panther, PhylomeDB
Homo sapiens (human):
AIM2 (absent in melanoma 2) HGNC
OrthoDB
Alliance orthologs 3
Homo sapiens (human):
MNDA (myeloid cell nuclear differentiation antigen)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Mus musculus (house mouse):
Ifi211 (interferon activated gene 211)
Alliance
DIOPT (Ensembl Compara, OMA, OrthoFinder, PANTHER, TreeFam)
Homo sapiens (human):
IFI16 (interferon gamma inducible protein 16)
Alliance
DIOPT (InParanoid, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB)
Mus musculus (house mouse):
Ifi204 (interferon activated gene 204)
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Homo sapiens (human):
PYHIN1 (pyrin and HIN domain family member 1)
Alliance
DIOPT (InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB)
Mus musculus (house mouse):
Ifi205 (interferon activated gene 205)
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Mus musculus (house mouse):
Ifi207 (interferon activated gene 207)
Alliance
DIOPT (InParanoid, OrthoFinder, TreeFam)
Mus musculus (house mouse):
Mndal (myeloid nuclear differentiation antigen like)
Alliance
DIOPT (Ensembl Compara, Hieranoid, PANTHER, TreeFam)
Latest Assembly:
Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Rnor_6.0 13 92,073,664 - 92,091,335 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 13 92,073,668 - 92,089,980 (-) Ensembl Rnor_5.0 13 96,545,815 - 96,606,181 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 13 89,752,997 - 89,770,167 (-) NCBI RGSC3.4 rn4 RGSC3.4 RGSC_v3.1 13 89,941,881 - 89,959,051 (-) NCBI Celera 13 85,620,545 - 85,638,000 (-) NCBI Celera Cytogenetic Map 13 q24 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of IFI204 mRNA CTD PMID:25380136 17beta-estradiol increases expression ISO RGD:1557521 6480464 Estradiol results in increased expression of IFI204 mRNA CTD PMID:19484750 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1557521 6480464 Tetrachlorodibenzodioxin results in increased expression of IFI204 mRNA CTD PMID:21041162 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1314506 6480464 Tetrachlorodibenzodioxin affects the expression of PYHIN1 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1314506 6480464 Tetrachlorodibenzodioxin results in increased expression of MNDA mRNA CTD PMID:26290441 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1557521 6480464 Trinitrobenzenesulfonic Acid results in increased expression of IFI204 mRNA CTD PMID:17982090 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1314506 6480464 Trinitrobenzenesulfonic Acid results in increased expression of MNDA mRNA CTD PMID:17982090 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:1557521 6480464 Glucosamine results in increased expression of IFI204 mRNA CTD PMID:17178593 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1557521 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IFI204 mRNA CTD PMID:16054899 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of IFI204 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane affects expression ISO RGD:1557521 6480464 4, 4'-diaminodiphenylmethane affects the expression of IFI16 mRNA CTD PMID:18648102 4-hydroxynon-2-enal decreases expression ISO RGD:1557521 6480464 4-hydroxy-2-nonenal results in decreased expression of IFI16 mRNA, 4-hydroxy-2-nonenal results in decreased expression of IFI204 mRNA CTD PMID:19191707 4-hydroxynon-2-enal decreases expression ISO RGD:1314505 6480464 4-hydroxy-2-nonenal results in decreased expression of MNDA mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide decreases expression ISO RGD:1557521 6480464 Fenretinide results in decreased expression of IFI16 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:1557521 6480464 Fenretinide results in increased expression of IFI16 mRNA, Fenretinide results in increased expression of IFI204 mRNA CTD PMID:16467112 , PMID:28973697 aldehydo-D-glucosamine increases expression ISO RGD:1557521 6480464 Glucosamine results in increased expression of IFI204 mRNA CTD PMID:17178593 all-trans-retinoic acid increases expression ISO RGD:1314505 6480464 Tretinoin results in increased expression of MNDA mRNA CTD PMID:17218384 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of IFI204 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:1314505 6480464 Antirheumatic Agents results in decreased expression of MNDA mRNA CTD PMID:24449571 benzo[a]pyrene decreases expression ISO RGD:1314505 6480464 Benzo(a)pyrene results in decreased expression of MNDA mRNA CTD PMID:20064835 benzo[a]pyrene decreases expression ISO RGD:1314506 6480464 Benzo(a)pyrene results in decreased expression of PYHIN1 mRNA CTD PMID:21569818 benzo[b]fluoranthene increases expression ISO RGD:1314506 6480464 benzo(b)fluoranthene results in increased expression of PYHIN1 mRNA CTD PMID:26377693 beta-D-glucosamine increases expression ISO RGD:1557521 6480464 Glucosamine results in increased expression of IFI204 mRNA CTD PMID:17178593 bis(2-chloroethyl) sulfide increases expression ISO RGD:1557521 6480464 Mustard Gas results in increased expression of IFI204 mRNA CTD PMID:15674844 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MNDA mRNA CTD PMID:25181051 buta-1,3-diene decreases expression ISO RGD:1314506 6480464 1, 3-butadiene results in decreased expression of PYHIN1 mRNA CTD PMID:29038090 carbon nanotube affects expression ISO RGD:1314506 6480464 Nanotubes, Carbon analog affects the expression of PYHIN1 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1557521 6480464 Nanotubes, Carbon analog results in increased expression of IFI204 mRNA, Nanotubes, Carbon results in increased expression of IFI204 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1314506 6480464 Nanotubes, Carbon analog results in decreased expression of MNDA mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1314506 6480464 Nanotubes, Carbon analog results in increased expression of MNDA mRNA more ... CTD PMID:25554681 chloroprene decreases expression ISO RGD:1314506 6480464 Chloroprene results in decreased expression of PYHIN1 mRNA CTD PMID:23125180 cisplatin increases expression ISO RGD:1557521 6480464 Cisplatin results in increased expression of IFI16 mRNA CTD PMID:21151649 clofibrate multiple interactions ISO RGD:1314506 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MNDA mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MNDA mRNA] CTD PMID:17585979 copper atom decreases expression EXP 6480464 Copper results in decreased expression of IFI204 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of IFI204 mRNA CTD PMID:30556269 cyclophosphamide increases expression ISO RGD:1557521 6480464 Cyclophosphamide results in increased expression of IFI204 mRNA CTD PMID:21041162 dexamethasone multiple interactions ISO RGD:1557521 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IFI204 mRNA CTD PMID:16054899 dexamethasone increases expression ISO RGD:1557521 6480464 Dexamethasone results in increased expression of IFI204 mRNA CTD PMID:21041162 dextran sulfate increases expression ISO RGD:1314506 6480464 Dextran Sulfate results in increased expression of PYHIN1 mRNA CTD PMID:23894361 dextran sulfate multiple interactions ISO RGD:1557521 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IFI204 mRNA CTD PMID:29950665 dichlorine increases expression ISO RGD:1557521 6480464 Chlorine results in increased expression of IFI204 mRNA CTD PMID:30189237 diclofenac increases expression ISO RGD:1314506 6480464 Diclofenac results in increased expression of MNDA mRNA CTD PMID:26934552 diethylstilbestrol increases expression ISO RGD:1557521 6480464 Diethylstilbestrol results in increased expression of IFI204 mRNA CTD PMID:21041162 dioxygen multiple interactions ISO RGD:1314506 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PYHIN1 mRNA CTD PMID:30529165 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MNDA mRNA CTD PMID:29391264 fluoranthene multiple interactions ISO RGD:1557521 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of IFI204 mRNA CTD PMID:28329830 fluoranthene multiple interactions ISO RGD:1314506 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of MNDA mRNA CTD PMID:28329830 furan increases expression EXP 6480464 furan results in increased expression of IFI204 mRNA CTD PMID:27387713 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MNDA mRNA CTD PMID:22061828 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:1314506 6480464 indeno(1 more ... CTD PMID:26377693 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of IFI204 mRNA CTD PMID:21396975 lipopolysaccharide affects expression ISO RGD:1557521 6480464 Lipopolysaccharides affects the expression of IFI204 mRNA CTD PMID:24056979 lipopolysaccharide multiple interactions ISO RGD:1557521 6480464 methyldithiocarbamate inhibits the reaction [Lipopolysaccharides affects the expression of IFI204 mRNA] CTD PMID:24056979 lipopolysaccharide increases expression ISO RGD:1557521 6480464 Lipopolysaccharides results in increased expression of IFI204 mRNA CTD PMID:25890327 , PMID:26582142 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of IFI204 mRNA CTD PMID:28801915 metam multiple interactions ISO RGD:1557521 6480464 methyldithiocarbamate inhibits the reaction [Lipopolysaccharides affects the expression of IFI204 mRNA] CTD PMID:24056979 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of IFI204 mRNA CTD PMID:25380136 nickel atom decreases expression ISO RGD:1314505 6480464 Nickel results in decreased expression of MNDA mRNA CTD PMID:23195993 nickel atom increases expression ISO RGD:1314505 6480464 Nickel results in increased expression of MNDA mRNA CTD PMID:24768652 , PMID:25583101 nonanoic acid increases expression ISO RGD:1557521 6480464 pelargonic acid results in increased expression of IFI204 mRNA CTD PMID:11379042 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of MNDA mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MNDA mRNA CTD PMID:25729387 ozone decreases expression ISO RGD:1314506 6480464 Ozone results in decreased expression of MNDA mRNA CTD PMID:16183385 paracetamol affects expression ISO RGD:1557521 6480464 Acetaminophen affects the expression of IFI204 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:1314506 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MNDA mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MNDA mRNA] CTD PMID:17585979 pentachlorophenol increases expression ISO RGD:1557521 6480464 Pentachlorophenol results in increased expression of IFI204 mRNA CTD PMID:23892564 pentachlorophenol increases expression ISO RGD:1314506 6480464 Pentachlorophenol results in increased expression of PYHIN1 mRNA CTD PMID:23892564 perfluorooctanoic acid increases expression ISO RGD:1314506 6480464 perfluorooctanoic acid results in increased expression of IFI211 mRNA CTD PMID:30711707 pirinixic acid decreases expression ISO RGD:1557521 6480464 pirinixic acid results in decreased expression of IFI204 mRNA CTD PMID:18445702 serpentine asbestos decreases expression ISO RGD:1314505 6480464 Asbestos, Serpentine results in decreased expression of MNDA mRNA CTD PMID:21148743 silver atom decreases expression ISO RGD:1557521 6480464 Silver results in decreased expression of IFI204 mRNA CTD PMID:27131904 silver atom affects expression ISO RGD:1314506 6480464 Silver affects the expression of PYHIN1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1557521 6480464 Silver results in decreased expression of IFI204 mRNA CTD PMID:27131904 silver(0) affects expression ISO RGD:1314506 6480464 Silver affects the expression of PYHIN1 mRNA CTD PMID:27131904 succimer multiple interactions ISO RGD:1314506 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MNDA mRNA CTD PMID:21641980 sulforaphane increases expression ISO RGD:1314505 6480464 sulforafan results in increased expression of MNDA mRNA CTD PMID:26833863 tamoxifen affects expression ISO RGD:1314506 6480464 Tamoxifen affects the expression of PYHIN1 mRNA CTD PMID:20937368 tetrachloromethane affects expression ISO RGD:1557521 6480464 Carbon Tetrachloride affects the expression of IFI204 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:1557521 6480464 Carbon Tetrachloride results in increased expression of IFI204 mRNA CTD PMID:29987408 tetrachloromethane increases expression ISO RGD:1314506 6480464 Carbon Tetrachloride results in increased expression of PYHIN1 mRNA CTD PMID:27339419 tetraphene decreases expression ISO RGD:1314506 6480464 benz(a)anthracene results in decreased expression of MNDA mRNA CTD PMID:26377693 titanium dioxide increases expression ISO RGD:1557521 6480464 titanium dioxide results in increased expression of IFI204 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:1557521 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IFI204 mRNA CTD PMID:29950665 titanium dioxide increases expression ISO RGD:1314506 6480464 titanium dioxide results in increased expression of IFI211 mRNA, titanium dioxide results in increased expression of PYHIN1 mRNA CTD PMID:23557971 , PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MNDA mRNA CTD PMID:25729387 valproic acid affects expression ISO RGD:1557521 6480464 Valproic Acid affects the expression of IFI16 mRNA CTD PMID:17292431 zidovudine multiple interactions ISO RGD:1314505 6480464 [Zidovudine co-treated with IFNA1 protein] results in increased expression of MNDA mRNA CTD PMID:20370541 
Gene-Chemical Interaction Annotations
